HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dima Suki Selected Research

Brain Neoplasms (Brain Tumor)

1/2021Effects of systemic therapy and local therapy on outcomes of 873 breast cancer patients with metastatic breast cancer to brain: MD Anderson Cancer Center experience.
8/2018Biological subtypes and survival outcomes in breast cancer patients with brain metastases in the targeted therapy era.
5/2015Breast cancer with brain metastases: clinicopathologic features, survival, and paired biomarker analysis.
4/2013A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors.
3/2011Multiple craniotomies in the management of multifocal and multicentric glioblastoma. Clinical article.
7/2010Adjuvant whole-brain radiation therapy after surgical resection of single brain metastases.
7/2009Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases.
5/2009Awake craniotomy for brain tumors near eloquent cortex: correlation of intraoperative cortical mapping with neurological outcomes in 309 consecutive patients.
3/2009Risk of intracranial hemorrhage and cerebrovascular accidents in non-small cell lung cancer brain metastasis patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dima Suki Research Topics

Disease

30Neoplasms (Cancer)
02/2022 - 01/2003
16Neoplasm Metastasis (Metastasis)
01/2021 - 11/2003
9Brain Neoplasms (Brain Tumor)
01/2021 - 03/2009
9Glioblastoma (Glioblastoma Multiforme)
11/2016 - 02/2005
7Glioma (Gliomas)
10/2014 - 01/2005
4Breast Neoplasms (Breast Cancer)
01/2021 - 01/2005
3Pain (Aches)
10/2015 - 01/2003
2Spinal Cord Compression
05/2017 - 12/2016
2Osteosarcoma (Osteogenic Sarcoma)
09/2014 - 05/2011
2Necrosis
11/2011 - 07/2008
1Medulloblastoma
01/2021
1Renal Cell Carcinoma (Grawitz Tumor)
01/2015
1Thrombosis (Thrombus)
11/2014
1Seizures (Absence Seizure)
04/2013
1Oligodendroglioma
11/2011
1Traumatic Brain Injuries (Traumatic Brain Injury)
09/2010
1Hemorrhage
07/2010
1Prostatic Neoplasms (Prostate Cancer)
05/2009
1Intracranial Hemorrhages (Intracranial Hemorrhage)
03/2009
1Sarcoma (Soft Tissue Sarcoma)
01/2009
1Spasm (Spasms)
09/2008
1Hemifacial Spasm
09/2008
1Hearing Loss (Hearing Impairment)
09/2008
1Postoperative Pain
08/2007
1Melanoma (Melanoma, Malignant)
01/2005
1Compression Fractures (Compression Fracture)
01/2003

Drug/Important Bio-Agent (IBA)

3epidermal growth factor receptor VIIIIBA
06/2007 - 02/2005
3ErbB Receptors (EGF Receptor)IBA
06/2007 - 02/2005
2Biomarkers (Surrogate Marker)IBA
08/2018 - 05/2015
2Estrogen ReceptorsIBA
05/2015 - 10/2007
2inulin trinicotinate monomethochloride (L-3)IBA
09/2014 - 06/2009
2Proteins (Proteins, Gene)FDA Link
11/2007 - 01/2005
1thiamine triphosphorate (TTP)IBA
01/2021
1Biological ProductsIBA
08/2018
1human ERBB2 proteinIBA
08/2018
1Progesterone Receptors (Progesterone Receptor)IBA
05/2015
1Hormones (Hormone)IBA
05/2015
1Phenytoin (Dilantin)FDA LinkGeneric
04/2013
1TitaniumIBA
01/2012
1Complement System Proteins (Complement)IBA
11/2011
1Platelet-Derived Growth FactorIBA
11/2011
1Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
11/2011
1Caspase 3 (Caspase-3)IBA
11/2011
1Glutamic Acid (Glutamate)FDA Link
09/2010
1Excitatory Amino AcidsIBA
09/2010
1Biological FactorsIBA
08/2010
1ElementsIBA
06/2009
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2009
1Dihydrotachysterol (AT 10)IBA
09/2008
1NF-kappa B (NF-kB)IBA
07/2008
1Thromboplastin (Tissue Factor)IBA
07/2008
1Small Interfering RNA (siRNA)IBA
11/2007
1p21-Activated KinasesIBA
11/2007
1GuanosineIBA
11/2007
1Analgesics (Analgesic Drugs)IBA
08/2007
1Mitogen-Activated Protein KinasesIBA
07/2006
1TOR Serine-Threonine KinasesIBA
07/2006
1CytokinesIBA
03/2006
1PercollIBA
03/2006
1Transcription Factors (Transcription Factor)IBA
01/2005
1Transcription Factor AP-2IBA
01/2005
1Indicators and Reagents (Reagents)IBA
01/2005

Therapy/Procedure

12Therapeutics
01/2021 - 03/2009
8Radiotherapy
02/2022 - 11/2003
6Craniotomy
05/2015 - 05/2009
3Lasers (Laser)
05/2017 - 10/2015
2Induced Hyperthermia (Thermotherapy)
05/2017 - 10/2015
2Drug Therapy (Chemotherapy)
01/2012 - 01/2009
1Adjuvant Chemotherapy
02/2022
1Preoperative Period
10/2015
1Aftercare (After-Treatment)
10/2015
1Stents
11/2014
1Adjuvant Chemoradiotherapy
03/2014
1Palliative Care (Palliative Therapy)
01/2014
1Particle Accelerators
10/2011
1Cautery
07/2010
1Surgical Decompression
05/2009
1Microvascular Decompression Surgery
09/2008
1Immunotherapy
03/2006
1Laparotomy
08/2004
1Kyphoplasty
01/2003
1Vertebroplasty
01/2003